Testing for HER2 status is crucial for determining the appropriate treatment strategy. Several methods are used for HER2 testing, including immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Accurate HER2 testing ensures that patients who are HER2-positive receive targeted therapies that can significantly improve their outcomes.
